News Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 21:08:45 06/03/2026 +03			5-day change	1st Jan Change
238.42 ^USD	-0.50%		-4.26%	+14.92%

05:01pm	Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment	MT
04:46pm	Oil Shock Meets Job Shock

All News

05:01pm	Halozyme Therapeutics Says Johnson & Johnson Wins FDA Approval for Blood Cancer Treatment	MT
04:46pm	Oil Shock Meets Job Shock
10:13am	An oil equation with several unknowns
03-05	Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line	PR
03-05	Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI Plus DARZALEX FASPRO For Relapsed/Refractory Multiple Myeloma	CI
03-05	Johnson & Johnson : Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line	PU
03-05	US FDA approves Johnson & Johnson's blood cancer drug after speedy review	RE
03-05	Johnson & Johnson's Janssen Biotech Unit Secures US FDA Approval for Multiple Myeloma Treatment	MT
03-05	US FDA approves JNJ's blood cancer drug	RE
03-05	Fda grants third approval under National Priority Voucher program	RE
03-05	United Therapeutics Seen as Top Pick on Multiple Near-Term Catalysts, UBS Says	MT
03-05	Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion	PR
03-05	Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion	AQ
03-05	The Year the Easy Narrative Broke
03-05	JPMorgan Adjusts Price Target on Johnson & Johnson to $250 From $225, Maintains Neutral Rating	MT
03-05	Markets rebound as risks linger
03-05	Coloplast Appoints Gavin Wood as New CEO	FW
03-05	Coloplast Names New CEO	MT
03-05	Johnson & Johnson launches website for direct-to-consumer sales	RE
03-05	J&J has launched J&J Direct website to sell drugs direct to U.S. consumers	RE
03-04	Coloplast A/S Announces CEO Changes	CI
03-04	Johnson & Johnson therapy nipocalimab granted U.S. FDA Fast Track designation in systemic lupus erythematosus	AQ
03-04	China commerce vice minister met with Johnson & Johnson VP	RE
03-03	Johnson & Johnson Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 11:10 AM
03-03	Johnson & Johnson Therapy Nipocalimab Granted U.S. FDA Fast Track designation in systemic lupus erythematosus	CI